(Q38076740)

28 August 2017

1 reference

title

Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes (English)

1 reference

28 August 2017

8

1 reference

28 August 2017

6

Reetta Kälviäinen

0 references

Emilio Perucca

9

object named as

Emilio Perucca

1 reference

28 August 2017

10

Torbjorn Tomson

1 reference

28 August 2017

2

Elinor Ben-Menachem

1 reference

28 August 2017

4

Avital Cnaan

1 reference

28 August 2017

Tracy Glauser

1

1 reference

28 August 2017

Blaise Bourgeois

3

1 reference

28 August 2017

Carlos Guerreiro

5

1 reference

28 August 2017

Reetta Kälviäinen

6

1 reference

28 August 2017

Richard Mattson

7

1 reference

28 August 2017

ILAE Subcommission on AED Guidelines

11

1 reference

28 August 2017

publication date

25 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

54

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

551-563

1 reference

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy

28 August 2017

cites work

1 reference

Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial

21 January 2018

1 reference

Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy

21 January 2018

1 reference

Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential Analysis.

21 January 2018

1 reference

A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy

21 January 2018

1 reference

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

21 January 2018

1 reference

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.

21 January 2018

1 reference

Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.

21 January 2018

1 reference

Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.

21 January 2018

1 reference

Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy

21 January 2018

1 reference

Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group)

21 January 2018

1 reference

Lamictal (lamotrigine) monotherapy for typical absence seizures in children

21 January 2018

1 reference

A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy

21 January 2018

1 reference

When antiepileptic drugs aggravate epilepsy

21 January 2018

1 reference

A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial

21 January 2018

1 reference

A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy

21 January 2018

1 reference

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

21 January 2018

1 reference

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy

21 January 2018

1 reference

Antiepileptic drug-induced worsening of seizures in children

21 January 2018

1 reference

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

21 January 2018

1 reference

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

21 January 2018

1 reference

Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison.

21 January 2018

1 reference

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial

21 January 2018

1 reference

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

21 January 2018

1 reference

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

21 January 2018

1 reference

A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy

21 January 2018

1 reference

Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India

21 January 2018

1 reference

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy

21 January 2018

1 reference

Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial

21 January 2018

1 reference

A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.

21 January 2018

1 reference

A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group

21 January 2018

1 reference

New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine

21 January 2018

1 reference

An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly

21 January 2018

1 reference

Some treatments cause seizure aggravation in idiopathic epilepsies (especially absence epilepsy).

21 January 2018

1 reference

The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults

21 January 2018

1 reference

Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies.

21 January 2018

1 reference

A comparison of phenytoin and valproate in previously untreated adult epileptic patients

21 January 2018

1 reference

Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment

21 January 2018

1 reference

Sulthiame as Monotherapy in Children with Benign Childhood Epilepsy with Centrotemporal Spikes: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EPI.12074

1 reference

28 August 2017

1 reference